These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19088396)

  • 1. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
    Tsuchida M; Kawashiri MA; Tada H; Takata M; Nohara A; Ino H; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M
    Circ J; 2009 May; 73(5):963-6. PubMed ID: 19088396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery bypass grafting in familial hypercholesterolemia.
    Kawasuji M; Sakakibara N; Takemura H; Matsumoto Y; Mabuchi H; Watanabe Y
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):364-9. PubMed ID: 7853888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term (14 years) effect of LDL apheresis on obstructive changes in aortocoronary saphenous-vein bypass grafts in a case of heterozygous familial hypercholesterolemia with the LDL receptor proline664 to leucine mutation.
    Takahashi K; Kobayashi J; Bujo H; Takahashi M; Taira K; Kaneko K; Tashiro J; Shinomiya M; Miyazaki A; Saito Y
    Intern Med; 2000 Oct; 39(10):804-9. PubMed ID: 11030204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
    Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
    Thompson GR; Maher VM; Matthews S; Kitano Y; Neuwirth C; Shortt MB; Davies G; Rees A; Mir A; Prescott RJ
    Lancet; 1995 Apr; 345(8953):811-6. PubMed ID: 7898227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy.
    Masaki N; Tatami R; Kumamoto T; Izawa A; Shimada Y; Takamatsu T; Katsushika S; Ishise S; Maruyama Y; Yoshimoto N
    Int Heart J; 2005 Sep; 46(5):833-43. PubMed ID: 16272774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of heterozygous familial hypercholesterolemia showing the regression of coronary atherosclerosis by LDL-apheresis].
    Nomura S; Kouzuma R; Komura T; Sadayasu T; Segawa J; Nakashima Y; Kuroiwa A
    Kokyu To Junkan; 1992 Mar; 40(3):299-302. PubMed ID: 1579754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Patients with Familial Hypercholesterolemia Who Were Successfully Weaned from Low-density Lipoprotein Apheresis after Treatment with Evolocumab.
    Tanaka A; Inaguma D; Watanabe Y; Ito E; Kamegai N; Shimogushi H; Shinjo H; Koike K; Otsuka Y; Takeda A
    Intern Med; 2017; 56(12):1531-1535. PubMed ID: 28626179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
    Saito Y; Shinomiya M; Shirai K; Yoshida S
    Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).
    Nishimura S; Sekiguchi M; Kano T; Ishiwata S; Nagasaki F; Nishide T; Okimoto T; Kutsumi Y; Kuwabara Y; Takatsu F; Nishikawa H; Daida H; Yamaguchi H
    Atherosclerosis; 1999 Jun; 144(2):409-17. PubMed ID: 10407502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
    Post Coronary Artery Bypass Graft Trial Investigators
    N Engl J Med; 1997 Jan; 336(3):153-62. PubMed ID: 8992351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia.
    Koga N
    Ther Apher; 1997 Aug; 1(3):260-70. PubMed ID: 10225750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.
    Reijman MD; Tromp TR; Hutten BA; Hovingh GK; Blom DJ; Catapano AL; Cuchel M; Dann EJ; Gallo A; Hudgins LC; Raal FJ; Ray KK; Sadiq F; Soran H; Groothoff JW; Wiegman A; Kusters DM; ;
    Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
    Mol MJ; Stalenhoef AF
    Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body in familial hypercholesterolemia.
    Jin H; Yao F; Li ZG; Xu ZY
    Thorac Cardiovasc Surg; 2009 Aug; 57(5):303-4. PubMed ID: 19629894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
    Zwiener RJ; Uauy R; Petruska ML; Huet BA
    J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of familial hypercholesterolemia; secession from LDL-apheresis by the drug treatment with potent statin and resin.
    Shiina Y; Homma Y; Oguma T; Fusegawa Y; Ozawa H; Handa S; Tanabe T
    Tokai J Exp Clin Med; 2005 Sep; 30(3):149-55. PubMed ID: 16285605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve replacement in a patient with premature coronary artery disease and calcific aortic stenosis complicated by heterozygous familial hypercholesterolemia.
    Bekele N; Agarwala A; Wang Z; Goldberg AC
    J Clin Lipidol; 2021; 15(6):793-795. PubMed ID: 34645588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.